Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

OTHER(1)
1 unique interventions1 categories

Analytics

Trial Phases

No phase data

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04056247Active Not Recruiting
Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments
Stage III Unresectable Non-Small Cell Lung CancerStage IIIb-d Malignant MelanomaStage IV Malignant Melanoma+2 more
PrincipalinvestigatorStart date: 2019-10-01

Research Network

Collaboration Network

42 collaborators·88 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ido Wolf, MD

Tel-Aviv Sourasky Medical Center

Similar
1 trials

Shared therapeutic areas:

Stage III Unresectable Non-Small Cell Lung CancerStage IIIb-d Malignant MelanomaStage IV Malignant Melanoma+2 more

Worked with same sponsors:

OncoHost Ltd.
Collaborated on 1 trial
Similarity Score54%

Antony Magliocco, MD

Protean BioDiagnostics

Similar
1 trials

Shared therapeutic areas:

Stage III Unresectable Non-Small Cell Lung CancerStage IIIb-d Malignant MelanomaStage IV Malignant Melanoma+2 more

Worked with same sponsors:

OncoHost Ltd.
Collaborated on 1 trial
Similarity Score54%

Eugenie Younger, MD

Gloucestershire Hospitals NHS Foundation Trust

Similar
1 trials

Shared therapeutic areas:

Stage III Unresectable Non-Small Cell Lung CancerStage IIIb-d Malignant MelanomaStage IV Malignant Melanoma+2 more

Worked with same sponsors:

OncoHost Ltd.
Collaborated on 1 trial
Similarity Score54%

Andreas Polychronis, MD

Mount Vernon Cancer Centre

Similar
1 trials

Shared therapeutic areas:

Stage III Unresectable Non-Small Cell Lung CancerStage IIIb-d Malignant MelanomaStage IV Malignant Melanoma+2 more

Worked with same sponsors:

OncoHost Ltd.
Collaborated on 1 trial
Similarity Score54%

Adam Berger, MD

Rutgers Cancer Institute

Similar
1 trials

Shared therapeutic areas:

Stage III Unresectable Non-Small Cell Lung CancerStage IIIb-d Malignant MelanomaStage IV Malignant Melanoma+2 more

Worked with same sponsors:

OncoHost Ltd.
Collaborated on 1 trial
Similarity Score54%

Astrid Ammendola, MD

Asklepios Klinik Gauting GmbH

Similar
1 trials

Shared therapeutic areas:

Stage III Unresectable Non-Small Cell Lung CancerStage IIIb-d Malignant MelanomaStage IV Malignant Melanoma+2 more

Worked with same sponsors:

OncoHost Ltd.
Collaborated on 1 trial
Similarity Score54%

Igor Puzanov, MD

Roswell Park

Similar
1 trials

Shared therapeutic areas:

Stage III Unresectable Non-Small Cell Lung CancerStage IIIb-d Malignant MelanomaStage IV Malignant Melanoma+2 more

Worked with same sponsors:

OncoHost Ltd.
Collaborated on 1 trial
Similarity Score54%

Louise Medley, MD

Torbay and South Devon NHS foundation

Similar
1 trials

Shared therapeutic areas:

Stage III Unresectable Non-Small Cell Lung CancerStage IIIb-d Malignant MelanomaStage IV Malignant Melanoma+2 more

Worked with same sponsors:

OncoHost Ltd.
Collaborated on 1 trial
Similarity Score54%

Andrew Conn, MD

Bradford Teaching Hospitals

Similar
1 trials

Shared therapeutic areas:

Stage III Unresectable Non-Small Cell Lung CancerStage IIIb-d Malignant MelanomaStage IV Malignant Melanoma+2 more

Worked with same sponsors:

OncoHost Ltd.
Collaborated on 1 trial
Similarity Score54%

David Vecente, MD

Hospital Universitario Virgen Macarena

Similar
1 trials

Shared therapeutic areas:

Stage III Unresectable Non-Small Cell Lung CancerStage IIIb-d Malignant MelanomaStage IV Malignant Melanoma+2 more

Worked with same sponsors:

OncoHost Ltd.
Collaborated on 1 trial
Similarity Score54%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04056247PrincipalInvestigator

Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments

Stage III Unresectable Non-Small Cell Lung CancerStage IIIb-d Malignant MelanomaStage IV Malignant Melanoma+2 more
Active Not Recruiting

All 1 trials loaded